Pheochromocytoma/paragangliomas

Clinical trials for Pheochromocytoma/paragangliomas explained in plain language.

Never miss a new study

Get alerted when new Pheochromocytoma/paragangliomas trials appear

Sign up with your email to follow new studies for Pheochromocytoma/paragangliomas, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New radiation drug targets Hard-to-Treat cancers

Disease control Recruiting now

This early-stage trial tests a radioactive drug that seeks out and delivers radiation directly to cancer cells with a specific protein (somatostatin receptor). It is for adults with advanced lung, kidney, head and neck, digestive tract, or adrenal gland tumors that cannot be remo…

Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMAS

Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC

Pheochromocytoma/paragangliomas

Get alerted when new Pheochromocytoma/paragangliomas trials appear

New radiation drug targets Hard-to-Treat cancers